Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 47, 2021 - Issue 4
Submit an article Journal homepage
268
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Novel risperidone orally disintegrating minitablets for pediatric use: patient acceptance and dose adjustment

George BebawyPharmaceutics Department, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7841-7218
ORCID Icon,
Magda SokarPharmaceutics Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
&
Ossama Y. AbdallahaPharmaceutics Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
Pages 542-551 | Received 15 Jan 2020, Accepted 09 Jan 2021, Published online: 06 Apr 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emine Dilek Özyılmaz & Tansel Comoglu. (2022) Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design. Drug Development and Industrial Pharmacy 48:11, pages 667-681.
Read now

Articles from other publishers (2)

Carmen-Maria Jîtcă, George Jîtcă, Bianca-Eugenia Ősz, Amalia Pușcaș & Silvia Imre. (2023) Stability of Oral Liquid Dosage Forms in Pediatric Cardiology: A Prerequisite for Patient’s Safety—A Narrative Review. Pharmaceutics 15:4, pages 1306.
Crossref
Arkadiusz Hejduk, Michał Teżyk, Emilia Jakubowska, Klaudia Krüger & Janina Lulek. (2022) Implementing the Design of Experiments (DoE) Concept into the Development Phase of Orodispersible Minitablets (ODMTs) Containing Melatonin. AAPS PharmSciTech 23:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.